What's Today

American Council General ne Anjuman-I-Islam ke taleemi nizam ki satayish ki

   Source: ROZNAMA RASHTRIYA SAHARA-25th September,2019

Team of IIT-B develops flood prediction system for cities

                              Source: THE INDIAN EXPRESS-23rd September,2019

 

DESIGNED BY THE BOOK

                        Source:THE ECONOMIC TIMES-26th September,2019

Manoj Kumar, co-founder of Araku Coffee, says his two favourite passions — design and books — combine to create the perfect den

 

Civil services mein numayendagi bhadhane ke liye hum apne naujawano ki aise madad karen!

                                             Source: INQUILAB-26th September,2019

Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?

Source:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383151/

There is substantial epidemiological evidence pointing to an increased incidence of breast cancer and morbidity in obese, prediabetic, and diabetic patients. In vitro studies strongly support metformin, a diabetic medication, in breast cancer therapy. Although metformin has been heralded as an exciting new breast cancer treatment, the principal consideration is whether metformin can be used as a generic treatment for all breast cancer types. I

 

Ranitidine may have impurity that can cause cancer, probe ordered

Source:
 https://timesofindia.indiatimes.com/india/ranitidine-may-have-impurity-that-can-cause-cancer-probe-ordered/articleshowprint/71285298.cms

 NEW DELHI: The Indian drug regulator has ordered an investigation into the popular anti-acidity drug Ranitidine for possible presence of an impurity that may cause cancer after recent reports and a decision by drug major Dr Reddy’s pulled the product off the shelves. The Central Drugs Standard Control Organisation, which regulates quality, safety and efficacy of medicines in India, has referred the matter to an expert committee for detailed examination.

 The panel will examine various brands of Ranitidine sold in the country. Though most international regulators including USFDA and EMA have not banned the drug, regulators have alerted public to be cautious and consult their doctors. Some regulators including the Health Canada and Health Sciences Authority (HSA) of Singapore have initiated recall as a precautionary measure.

 

Now, tackle Chagas disease with Alzheimer’s medication

Source:
https://www.asianage.com/life/health/240919/now-tackle-chagas-disease-with-alzheimers-medication.html

Memantine lowered levels of the parasite by 40 per cent and increased survival rates from 7.5 per cent to 12.5 per cent.

Washington: Memantine, a drug used to treat Alzheimer's, can also prove effective in treating Chagas, a tropical disease, a new study has found.

The drugs currently used to treat Chagas disease, have serious side effects and limited use in those with chronic disease. However, researchers have found that memantine can diminish the number of parasites in mice infected with Chagas disease, and also increase the survival rate of the animals.

The findings of this study were published in the Journal PLOS Neglected Tropical Diseases.

Chagas can be divided into acute and chronic phases, with the clinical phase causing heart, esophagus or intestinal symptoms.

The two drugs that have been used to treat Chagas for the last 50 years -- nifurtimox and benznidazole -- are highly effective in the acute phase but used sparingly in the chronic phase due to serious side effects that occur with long-term treatment.

Education and Employment: At Grassroots Level, Robotics Treads a Fine Line in India

 Source:
 https://www.news18.com/news/tech/education-and-employment-at-grassroots-level-robotics-treads-a-fine-line-in-india-2321263.html

 

The key to seeing faster growth in robotics and automation technologies lies in early investments across India’s education system, as well as its SMEs.